Stock Spotlights Archives - Page 16 of 20

FridayAug 12, 2022 12:40 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Positioning Berubicin Clinical Development Program for Success

CNS Pharmaceuticals (NASDAQ: CNSP) is currently recruiting patients for a phase II study evaluating the efficacy and safety of Berubicin, its lead drug candidate for treating glioblastoma multiforme (“GBM”), the most aggressive, deadly and treatment-resistant type of cancer that forms in the brain. Recently, the company announced that the FDA had approved an amendment to the study’s protocol, boosting its Berubicin clinical development program. “The amendment expands eligibility for its potentially pivotal study to patients who have received additional treatments as part of the first-line therapy,” explains a recent article. “The key objectives of the amendment, according to CNS Pharmaceuticals…

WednesdayAug 03, 2022 2:35 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition of a phase 1 N,N-Dimethyltryptamine (“N,N-DMT”) study, the largest DMT study to date. The study provides key data relating to the company’s proprietary CYB004 substance with the potential to effectively treat anxiety disorders. “The phase 1 EBRX-101 study, now named CYB004-E, was acquired from Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) FSE: 1XU1) through Cybin IRL Limited, Cybin’s wholly owned subsidiary… The adaptive, randomized, double-blinded, placebo-controlled, single-ascending-dose study produced notable results. According to the…

TuesdayAug 02, 2022 1:50 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology Helping Innovators of Today, Leaders of Tomorrow

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) patented DehydraTECH(TM) has been regarded as one of the most innovative drug delivery technologies in years, proving useful in delivering a wide range of active pharmaceutical ingredients in a more palatable and effective way. Studies have also demonstrated DehydraTECH’s ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances, with cannabinoids by as much as 27x compared to standard industry formulations, a benefit that opens significant possibilities for important drug delivery. “DehydraTECH’s application in the cannabis sector is seeing a boom, particularly with the recent expansion of Boldt Runners Corporation, a…

FridayJul 29, 2022 2:17 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Leveraging Strategic Developments to Bring Its FIVE EV Crossover to Market

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, recently reported the results of its solid-state polymer battery testing. According to a recent article that contains excerpts from a Benzinga Brief, “Testing results from BIC [Battery Innovation Center] show the solid-state polymer cell, rated at 300 Ah and 3.7 volts, tested at 343.28 Ah at 4.2 volts, exceeding expectations, and is in line with test tolerance from previous EV Grid test results. The data supports solid-state polymer battery cell technology that, when scaled to the vehicle pack level and at a 150-kilowatt hour equivalent, can deliver over 600 miles…

FridayJul 29, 2022 1:30 pm

TinyGemsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Looking to Capitalize on Booming iGaming, Esports Markets

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, intends to capitalize on the burgeoning iGaming market expected to reach $127 billion by 2025 from $76.8 billion in 2020, buoyed by growth in Europe, the U.S. and Asia. “Golden Matrix’s GM-X system and newly launched GMX-Ag platform are a gold standard for the iGaming market, delivering access to 10,000+ games from over 25 leading providers. More than 635 unique casino operations use Golden Matrix’s platform to serve more than 7 million registered users. The company made its entrance into the lucrative European markets…

ThursdayJul 28, 2022 12:22 pm

TinyGemsBreaks – QSAM Biosciences Inc. (QSAM) Targeting Significant Unmet Medical Need with CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing a new class of drugs called radiopharmaceuticals that deliver radiation therapy directly and specifically to cancer cells. The company’s lead drug candidate, CycloSam(R), is a clinical-stage bone-seeking radiopharmaceutical designed to deliver targeted radiation safely and precisely to tumors in the bone. “QSAM is leading the charge to evaluate a new treatment for bone cancer and other related, underserved diseases. The company’s pioneering efforts are evident as the first patient has completed treatment in the company’s clinical trial designed to study the effect of its proprietary radiopharmaceutical technology: CycloSam(R),” a recent article reads.…

WednesdayJul 27, 2022 1:28 pm

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Poised with Strong In-Market Brand Portfolio, Cultivation and Export Capabilities

Flora Growth Corp. (NASDAQ: FLGC) recently reported that its board of directors had authorized the repurchase of up to $5 million of its outstanding common shares. “These recent developments highlight Flora management’s confidence in where the company is headed and its potential for growth as the year progresses. It also assures shareholders of the company’s commitment to driving shareholder value and exploring various opportunities to do so. As such, this only emphasizes Flora’s value as a good investment,” a recent article reads. “While making the announcement, Luis Merchan, Flora’s chairman and CEO, noted: ‘Flora continues to move assertively to execute…

MondayJul 25, 2022 2:29 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Committed to Becoming Prominent International Player in Lidar Space

Cepton (NASDAQ: CPTN) recently opened a newly renovated office in Metro Detroit (Troy, Michigan). The office is intended to enable the company to continue to forge close relationships with automakers centered around the heart of the U.S. auto industry. “Having a strong presence in Detroit not only enables us to keep up with the latest trend in the industry but also makes us part of that trend – we are here to demonstrate how lidar is essential to the future of mobility, with our product experts driving informative communications and our application engineers working in the field,” a recent article…

FridayJul 22, 2022 2:14 pm

TinyGemsBreaks – Why QSAM Biosciences Inc. (QSAM) Is ‘One to Watch’

QSAM Biosciences (OTCQB: QSAM), a clinical-stage biotechnology company, is focused on bringing to market targeted therapeutic radiopharmaceuticals. “The company is committed to advancing the fight against cancer through the discovery, development and delivery of effective treatment options for adult and pediatric patients,” a recent article reads. “CycloSam(R), QSAM Biosciences’ initial technology, is a clinical-stage bone targeting radiopharmaceutical invented by world-renowned scientists at IsoTherapeutics Group LLC. … CycloSam is designed to selectively target sites of high bone mineral turnover to deliver a prescribed tumor-killing dose of radiation to the tumor sites while minimizing radiation exposure to nearby healthy tissue. These parameters…

ThursdayJul 21, 2022 2:56 pm

TinyGemsBreaks – Golden Matrix Group Inc.’s (NASDAQ: GMGI) GMX-Ag System Facilitating Brand Expansion, Global Market Penetration

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, has been a key beneficiary of a trend that has seen hundreds of gambling platforms opt for white label product offerings from third-party providers. GMGI provides its end customers with access to a substantial portfolio of upwards of 10,000 games. “Golden Matrix Group has looked to cater to growing demand from online gaming platforms, most recently through the launch of its B2B aggregate gaming system, GMX-Ag. The turnkey iGaming system seeks to offer online platforms with an optimal casino, sportsbook and live gaming offering…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: Stock Spotlights